Preferred Label : besifloxacin;

MeSH note : structure in first source;

CISMeF synonym : 7-((3R)-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; BOL-303224-A; besivance;

MeSH synonym : 7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;

MeSH Related Number : 7506A6J57T;

Is substance : O;

UNII : BFE2NBZ7NX;

InChIKey : QFFGVLORLPOAEC-SNVBAGLBSA-N;

Details


Main resources

You can consult :


Summary Basis of Decision (SBD) for BESIVANCE
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00019
2010
false
Canada
French
English
antibiotic therapy
besifloxacin
besifloxacin
azepines
azepines
fluoroquinolones
fluoroquinolones
ophthalmic solutions
anti-bacterial agents
anti-bacterial agents
drug approval
treatment outcome
conjunctivitis, bacterial
infant
child
adolescent
adult
drug evaluation, preclinical
canada
administration, ophthalmic
drug information
besifloxacin
Product containing precisely besifloxacin 6 milligram/1 milliliter conventional release eye suspension (clinical drug)

---
Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.